AZELAPRAG BIOAGE - AN OVERVIEW

In December, BioAge declared a multi-calendar year investigate collaboration with Novartis to detect and validate novel therapeutic targets within the intersection of aging biology and exercise, combining BioAge's longitudinal human growing old datasets with Novartis abilities in work out biology.For MASH developers, a race for money: Akero Therape